195 related articles for article (PubMed ID: 29050251)
1.
Zhang Z; Chen S; Chen S; Chen G; Zhang R; Li J; Qu J
Oncotarget; 2017 Sep; 8(41):69916-69923. PubMed ID: 29050251
[TBL] [Abstract][Full Text] [Related]
2. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of SF3B1 mutations in patients with myelodysplastic syndromes: A meta-analysis.
Jafari PA; Sadeghian MH; Miri HH; Sadeghi R; Bagheri R; Lavasani S; Souri S
Crit Rev Oncol Hematol; 2020 Jan; 145():102832. PubMed ID: 31812130
[TBL] [Abstract][Full Text] [Related]
4. ZAP-70 in chronic lymphocytic leukemia: A meta-analysis.
Liu Y; Wang Y; Yang J; Bi Y; Wang H
Clin Chim Acta; 2018 Aug; 483():82-88. PubMed ID: 29680229
[TBL] [Abstract][Full Text] [Related]
5.
Miao Y; Zou YX; Gu DL; Zhu HC; Zhu HY; Wang L; Liang JH; Xia Y; Wu JZ; Shao CL; Fan L; Zhang Z; Xu W; Li JY
Ann Transl Med; 2019 Apr; 7(8):176. PubMed ID: 31168457
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis.
Qin Y; Shen K; Liu T; Ma H
BMC Cancer; 2023 Jun; 23(1):527. PubMed ID: 37291515
[TBL] [Abstract][Full Text] [Related]
7. Ofatumumab regimens in chronic lymphocytic leukemia: a meta-analysis.
Ashoub MH; Naseri A; Mohammadi P; Mohammadi M
Ann Hematol; 2023 Jun; 102(6):1301-1306. PubMed ID: 37138022
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of ATM mutations in chronic lymphocytic leukemia: A meta-analysis.
Baghaei Vaji F; Boroumand Nasr A; Rezvani A; Ayatollahi H; Goudarzi S; Lavasani S; Bagheri R
Leuk Res; 2021 Dec; 111():106729. PubMed ID: 34735935
[TBL] [Abstract][Full Text] [Related]
9. SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients.
Mitsui T; Koiso H; Nakahashi H; Saitoh A; Shimizu H; Ishizaki T; Ogawa Y; Takizawa M; Yokohama A; Saitoh T; Jinbo T; Ogura H; Handa H; Sawamura M; Sakura T; Karasawa M; Murakami H; Nojima Y; Tsukamoto N
Int J Hematol; 2016 Feb; 103(2):219-26. PubMed ID: 26588928
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of microRNA-155 in patients with leukemia: A meta-analysis.
Zhang X; Wang Y; Guo Q; Diao Y; Liu H; Song G; Wang W; Zhang Z; Yin H; Li L
Clin Chim Acta; 2018 Aug; 483():6-13. PubMed ID: 29654787
[TBL] [Abstract][Full Text] [Related]
11. Prognostic correlation of NOTCH1 and SF3B1 mutations with chromosomal abnormalities in chronic lymphocytic leukemia patients.
Sadria R; Motamed N; Saberi Anvar M; Mehrabani Yeganeh H; Poopak B
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1757. PubMed ID: 36411516
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of circulating tumor DNA in patients with melanoma: A systematic review and meta-analysis.
Feng SN; Cen XT; Tan R; Wei SS; Sun LD
Transl Oncol; 2021 Jun; 14(6):101072. PubMed ID: 33744725
[TBL] [Abstract][Full Text] [Related]
13. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
14. SF3B1 mutations in chronic lymphocytic leukemia.
Wan Y; Wu CJ
Blood; 2013 Jun; 121(23):4627-34. PubMed ID: 23568491
[TBL] [Abstract][Full Text] [Related]
15. IMMUNOPHENOTYPE OF LEUKEMIC CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH NOTCH1 AND SF3B1 GENE MUTATIONS.
Golyarnik N; Абраменко І; Movchan G; Martina Z; Dyagil I; Chumak A; Bazyka D
Exp Oncol; 2023 Dec; 45(3):322-327. PubMed ID: 38186023
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of NOTCH1, MYD88, and SF3B1 mutations in Polish patients with chronic lymphocytic leukemia.
Putowski M; Podgórniak M; Piróg M; Knap J; Zaleska J; Purkot J; Zawiślak J; Zakrzewska E; Karczmarczyk A; Własiuk P; Subocz E; Giannopoulos K
Pol Arch Intern Med; 2017 Apr; 127(4):238-244. PubMed ID: 28424451
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of the Platelet-to-Lymphocyte Ratio in Patients With Melanoma: A Meta-Analysis.
Zhang F; Gong W
Front Oncol; 2020; 10():1116. PubMed ID: 32850320
[No Abstract] [Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 and prognosis in patients with malignant pleural mesothelioma: a meta-analysis and bioinformatics study.
Jin L; Gu W; Li X; Xie L; Wang L; Chen Z
Ther Adv Med Oncol; 2020; 12():1758835920962362. PubMed ID: 33062064
[TBL] [Abstract][Full Text] [Related]
20.
López-Oreja I; Gohr A; Playa-Albinyana H; Giró A; Arenas F; Higashi M; Tripathi R; López-Guerra M; Irimia M; Aymerich M; Valcárcel J; Bonnal S; Colomer D
Life Sci Alliance; 2023 Nov; 6(11):. PubMed ID: 37562845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]